| OSCIX | RAIIX | OSCIX / RAIIX | |
| Total Expense Ratio | 0.99 | 1.16 | 85% |
| Annual Report Gross Expense Ratio | 0.99 | 1.16 | 85% |
| Fund Existence | 14 years | 14 years | - |
| Gain YTD | 2.553 | 5.824 | 44% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.55B | 400M | 637% |
| Annual Yield % from dividends | 1.85 | 2.31 | 80% |
| Returns for 1 year | -3.19 | 29.86 | -11% |
| Returns for 3 years | -11.89 | 33.86 | -35% |
| Returns for 5 years | -31.06 | -1.24 | 2,510% |
| Returns for 10 years | 16.26 | 109.92 | 15% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFCIX | 35.45 | 0.24 | +0.68% |
| JHancock Fundamental All Cap Core I | |||
| CMRCX | 10.18 | 0.04 | +0.39% |
| Calamos Merger Arbitrage C | |||
| BINCX | 26.15 | 0.08 | +0.31% |
| Brandes International Small Cap Equity C | |||
| FBIOX | 25.93 | N/A | N/A |
| Fidelity Select Biotechnology | |||
| FWOAX | 19.34 | N/A | N/A |
| Fidelity Advisor Women's Leadership A | |||